Άρθρα με εντολές δημόσιας πρόσβασης - Darren TysonΜάθετε περισσότερα
Δεν είναι διαθέσιμο πουθενά: 2
Annexin A2 positively contributes to the malignant phenotype and secretion of IL‐6 in DU145 prostate cancer cells
J Inokuchi, N Narula, DS Yee, DW Skarecky, A Lau, DK Ornstein, ...
International journal of cancer 124 (1), 68-74, 2009
Εντολές: US National Institutes of Health
What lies beneath: looking beyond tumor genetics shows the complexity of signaling networks underlying drug sensitivity
V Quaranta, DR Tyson
Science Signaling 6 (294), pe32-pe32, 2013
Εντολές: US National Institutes of Health
Διαθέσιμο κάπου: 37
Quantifying drug combination synergy along potency and efficacy axes
CT Meyer, DJ Wooten, BB Paudel, J Bauer, KN Hardeman, D Westover, ...
Cell systems 8 (2), 97-108. e16, 2019
Εντολές: US National Science Foundation, US National Institutes of Health, V …
Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data
DR Tyson, SP Garbett, PL Frick, V Quaranta
Nature methods 9 (9), 923-928, 2012
Εντολές: US National Institutes of Health
An unbiased metric of antiproliferative drug effect in vitro
LA Harris, PL Frick, SP Garbett, KN Hardeman, BB Paudel, CF Lopez, ...
Nature methods 13 (6), 497-500, 2016
Εντολές: US National Science Foundation, US National Institutes of Health
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers
DJ Wooten, SM Groves, DR Tyson, Q Liu, JS Lim, R Albert, CF Lopez, ...
PLoS computational biology 15 (10), e1007343, 2019
Εντολές: US National Science Foundation, US National Institutes of Health, A*Star …
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
AB Hanker, MV Estrada, G Bianchini, PD Moore, J Zhao, F Cheng, ...
Cancer research 77 (12), 3280-3292, 2017
Εντολές: US National Institutes of Health
Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer
A Sewell, B Brown, A Biktasova, GB Mills, Y Lu, DR Tyson, N Issaeva, ...
Clinical cancer research 20 (9), 2300-2311, 2014
Εντολές: US National Institutes of Health
Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis
D Hoshino, J Jourquin, SW Emmons, T Miller, M Goldgof, K Costello, ...
Science signaling 5 (241), ra66-ra66, 2012
Εντολές: US National Institutes of Health
The contribution of age structure to cell population responses to targeted therapeutics
P Gabriel, SP Garbett, V Quaranta, DR Tyson, GF Webb
Journal of theoretical biology 311, 19-27, 2012
Εντολές: US National Institutes of Health
Dependence on glycolysis sensitizes BRAF-mutated melanomas for increased response to targeted BRAF inhibition
KN Hardeman, C Peng, BB Paudel, CT Meyer, T Luong, DR Tyson, ...
Scientific reports 7 (1), 42604, 2017
Εντολές: US National Institutes of Health
A predictive mathematical modeling approach for the study of doxorubicin treatment in triple negative breast cancer
MT McKenna, JA Weis, SL Barnes, DR Tyson, MI Miga, V Quaranta, ...
Scientific reports 7 (1), 5725, 2017
Εντολές: US National Institutes of Health
Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling
J Inokuchi, A Lau, DR Tyson, DK Ornstein
Carcinogenesis 30 (7), 1082-1088, 2009
Εντολές: US National Institutes of Health
A nonquiescent “idling” population state in drug-treated, BRAF-mutated melanoma
BB Paudel, LA Harris, KN Hardeman, AA Abugable, CE Hayford, ...
Biophysical journal 114 (6), 1499-1511, 2018
Εντολές: US National Institutes of Health
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer
SM Groves, GV Ildefonso, CO McAtee, PMM Ozawa, AS Ireland, ...
Cell systems 13 (9), 690-710. e17, 2022
Εντολές: US National Science Foundation, US National Institutes of Health
An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability
CE Hayford, DR Tyson, CJ Robbins III, PL Frick, V Quaranta, LA Harris
PLoS Biology 19 (6), e3000797, 2021
Εντολές: US National Institutes of Health, Lung Cancer Research Foundation, USA
Quantifying heterogeneity and dynamics of clonal fitness in response to perturbation
PL Frick, BB Paudel, DR Tyson, V Quaranta
Journal of cellular physiology 230 (7), 1403-1412, 2015
Εντολές: US National Institutes of Health
Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies
ED Wirtz, D Hoshino, AT Maldonado, DR Tyson, AM Weaver
JAMA Otolaryngology–Head & Neck Surgery 141 (6), 543-549, 2015
Εντολές: US National Institutes of Health
Trait variability of cancer cells quantified by high-content automated microscopy of single cells
V Quaranta, DR Tyson, SP Garbett, B Weidow, MP Harris, W Georgescu
Methods in enzymology 467, 23-57, 2009
Εντολές: US National Institutes of Health
Beyond programmed death-ligand 1: B7-H6 emerges as a potential immunotherapy target in SCLC
PL Thomas, SM Groves, YK Zhang, J Li, P Gonzalez-Ericsson, ...
Journal of Thoracic Oncology 16 (7), 1211-1223, 2021
Εντολές: US National Institutes of Health
Τα στοιχεία έκδοσης και χρηματοδότησης καθορίζονται αυτόματα από ένα πρόγραμμα υπολογιστή